By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters has sold $100 million worth of 3.75 percent Series A Senior Notes due Feb. 1, 2015, in a private placement with institutional purchasers, the firm said in a filing with the US Securities and Exchange Commission today.

The placement was made yesterday and is the first of two senior notes offerings. In the second, expected to take place on March 1, 2010, Waters intends to sell $100 million worth of 5 percent Series B Senior Notes due Feb. 1, 2020.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.